NervGen Pharma: Stocks Undervalued by Analyst Consensus on TSX-V (NGEN)
NervGen Pharma is among the group of undervalued stocks on the TSX Venture Exchange. This means the consensus value for each stock on this list is above its current price.
This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are held primarily for capital appreciation. There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.
Symbol | Name | Close Price | Target Year | Target Price Mean | Currency | Target Price Number of Estimates |
---|---|---|---|---|---|---|
QIPT-X | Quipt Home Medical Corp | 7.44 | 2,022 | 11.956 | CAD | 7 |
FCA-U-X | Firm Capital Apartment REIT | 7.64 | 2,021 | 10.666 | CAD | 1 |
FIL-X | Filo Mining Corp | 8.88 | 2,021 | 13.5 | CAD | 7 |
HITI-X | High Tide Inc | 9.09 | 2,022 | 17.5 | CAD | 2 |
NGEN-X | NervGen Pharma Corp | 2.06 | 2,021 | 6 | CAD | 1 |
SLHG-X | Skylight Health Group Inc | 3.95 | 2,021 | 7.6 | CAD | 4 |
ODV-X | Osisko Development Corp | 5.25 | 2,021 | 11 | CAD | 3 |
AMC-X | Arizona Metals Corp | 3.96 | 2,021 | 8.167 | CAD | 3 |
PVT-X | Pivotree Inc | 5.38 | 2,021 | 11.875 | CAD | 4 |
CNC-X | Canada Nickel Co Inc | 2.79 | 2,022 | 6.075 | CAD | 2 |
TTR-X | Titanium Transportation Group Inc | 3.08 | 2,021 | 6.083 | CAD | 3 |
SJR-A-X | Shaw Communications Inc | 37 | 2,022 | 40.5 | CAD | 8 |
NEXE-X | NEXE Innovations Inc | 0.83 | 2,022 | 5.25 | CAD | 1 |
MTA-X | Metalla Royalty & Streaming Ltd | 9.13 | 2,021 | 14 | CAD | 4 |
LA-X | Los Andes Copper Ltd | 7 | 2,022 | 16 | CAD | 1 |
BSR-X | Bluestone Resources Inc | 1.4 | 2,021 | 4.5 | CAD | 4 |
GBR-X | Great Bear Resources Ltd | 13.15 | 2,021 | 26.393 | CAD | 7 |
PINK-X | Perimeter Medical Imaging AI Inc | 2.51 | 2,021 | 5.8 | CAD | 3 |
SDE-X | Spartan Delta Corp | 4 | 2,021 | 8.285 | CAD | 10 |
OIII-X | O3 Mining Inc | 2.08 | 2,021 | 5.188 | CAD | 4 |
WE-X | WeCommerce Holdings Ltd | 11.5 | 2,021 | 21 | CAD | 2 |
RECO-X | Reconnaissance Energy Africa Ltd | 6.2 | 2,021 | 16 | CAD | 1 |
ARTG-X | Artemis Gold Inc | 5.24 | 2,021 | 11.5 | CAD | 8 |
NXH-X | Next Hydrogen Solutions Inc | 6.7 | 2,021 | 12 | CAD | 1 |
ITR-X | Integra Resources Corp | 3.13 | 2,021 | 7.707 | CAD | 7 |
More about NervGen Pharma Corp
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.